FDA Feels Heat On Drug Pricing And Generic Labeling Rule
This article was originally published in The Pink Sheet Daily
Executive Summary
House subcommittee chair suggests agency taking contradictory positions by worrying about pricing while proposing reg that could increase drug costs.